Is Wall Street Immune to Anthrax?
So far, investors have taken bioterrorism in stride. If more attacks happen, though, that may well be a different story
By Amy Tsao
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like:
- Fewest Jobless Claims Since 1973 Show Firm U.S. Job Market
- Germans Are Going Wild for a Show Set During the Dawn of the Nazis
- Greenwich Mansion Listings Pulled to Wait for a Better Day
- The U.K.'s $86 Billion Pension Problem Is About to Solve Itself
- U.S. Stocks Climb With Treasuries as Dollar Slides: Markets Wrap